Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1301
First Financial Corp
THFF
$868M
| $573K | ﹤0.01% |
10,576
+8
| +0.1% | +$398 |
2014 Q1
45 quarters
|
|
1302
Impinj
PI
$5.87B
| $571K | ﹤0.01% |
5,142
| – | – |
2024 Q3
3 quarters
|
|
1303
Aurinia Pharmaceuticals
AUPH
$2.21B
| $568K | ﹤0.01% |
67,015
+27
| +0% | +$216 |
2024 Q1
5 quarters
|
|
1304
Phibro Animal Health
PAHC
$1.54B
| $567K | ﹤0.01% |
22,203
-988
| -4% | -$21.5K |
2024 Q1
5 quarters
|
|
1305
Kinder Morgan
KMI
$74.3B
| $565K | ﹤0.01% |
19,217
-557
| -3% | -$15.3K |
2013 Q2
48 quarters
|
|
1306
Alaska Air
ALK
$3.99B
| $561K | ﹤0.01% |
11,332
-322
| -3% | -$15.6K |
2025 Q1
1 quarter
|
|
1307
UFP Industries
UFPI
$4.18B
| $560K | ﹤0.01% |
5,638
-112
| -2% | -$11.3K |
2017 Q1
33 quarters
|
|
1308
Darling Ingredients
DAR
$9.84B
| $560K | ﹤0.01% |
14,764
-296
| -2% | -$9.74K |
2020 Q1
21 quarters
|
|
1309
Icon
ICLR
$13B
| $559K | ﹤0.01% |
3,840
| – | – |
2019 Q4
22 quarters
|
|
1310
Kennametal
KMT
$2.36B
| $557K | ﹤0.01% |
24,281
+4,502
| +23% | +$93.8K |
2013 Q2
48 quarters
|
|
1311
Saia
SAIA
$8.9B
| $555K | ﹤0.01% |
2,026
-120
| -6% | -$34.2K |
2017 Q4
30 quarters
|
|
1312
Camden Property Trust
CPT
$11.3B
| $554K | ﹤0.01% |
4,917
+3,570
| +265% | +$412K |
2024 Q2
4 quarters
|
|
1313
Zebra Technologies
ZBRA
$17.8B
| $549K | ﹤0.01% |
1,782
-90
| -5% | -$24.4K |
2024 Q3
3 quarters
|
|
1314
Midland States Bancorp
MSBI
$661M
| $549K | ﹤0.01% |
31,719
+6,419
| +25% | +$109K |
2016 Q4
34 quarters
|
|
1315
Oshkosh
OSK
$7.88B
| $545K | ﹤0.01% |
4,804
-1,357
| -22% | -$132K |
2013 Q2
48 quarters
|
|
1316
Kaspi.kz JSC
KSPI
$18B
| $539K | ﹤0.01% |
6,345
| – | – |
2024 Q1
5 quarters
|
|
1317
DELISTED
Y-mAbs Therapeutics
YMAB
| $539K | ﹤0.01% |
119,425
-34,028
| -22% | -$153K |
2023 Q3
7 quarters
|
|
1318
BRC Group Holdings
RILY
$186M
| $534K | ﹤0.01% |
179,960
+78,847
| +78% | +$242K |
2024 Q3
3 quarters
|
|
1319
Allegion
ALLE
$13B
| $533K | ﹤0.01% |
3,696
+917
| +33% | +$125K |
2017 Q4
30 quarters
|
|
1320
Ball Corp
BALL
$16B
| $531K | ﹤0.01% |
9,474
+8,163
| +623% | +$426K |
2013 Q2
48 quarters
|
|
1321
Avis
CAR
$3.77B
| $527K | ﹤0.01% |
3,119
-2,643
| -46% | -$285K |
2014 Q2
44 quarters
|
|
1322
Global Industrial
GIC
$1.67B
| $527K | ﹤0.01% |
19,493
-5,164
| -21% | -$130K |
2025 Q1
1 quarter
|
|
1323
Teradata
TDC
$2.78B
| $524K | ﹤0.01% |
23,486
-484
| -2% | -$10.5K |
2013 Q2
48 quarters
|
|
1324
Cabaletta Bio
CABA
$275M
| $524K | ﹤0.01% |
344,540
+1,129
| +0.3% | +$1.76K |
2024 Q3
3 quarters
|
|
1325
Chord Energy
CHRD
$8B
| $522K | ﹤0.01% |
5,392
-396
| -7% | -$37.7K |
2018 Q2
28 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.